Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06395090
Title A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01)
Acronym MK-9999-01B/LIGHTBEAM-U01
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Yale-New Haven Hospital ( Site 2012) RECRUITING New Haven Connecticut 06510 United States Details
University of Iowa-Holden Comprehensive Cancer Center ( Site 2017) RECRUITING Iowa City Iowa 52242 United States Details
Rutgers Cancer Institute of New Jersey ( Site 2008) RECRUITING New Brunswick New Jersey 08903 United States Details
New York Medical College ( Site 2023) RECRUITING Valhalla New York 10595 United States Details
Intermountain - Primary Children's Hospital ( Site 2014) RECRUITING Salt Lake City Utah 84113 United States Details
Seoul National University Hospital-Pediatrics ( Site 2972) RECRUITING Seoul 03080 Korea, Republic of Details
Asan Medical Center-Pediatrics - Pedicatric Oncology ( Site 2973) RECRUITING Seoul 05505 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field